Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.

By A. Cameron, M. Ewen, D. Ross-Degnan, D. Ball, R. Laing. The Lancet, 2009

922 citations recorded by the source corpus.

Subfields: Economics and Econometrics

View Paper: https://www.semanticscholar.org/paper/04ed96d27f7c910e4bc84f35902fed6b08a31701

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. T. Seuring
2. M. Suhrcke
3. O. Archangelidi

Citations in the corpus

• The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015, positive): “…across countries could be the economic wealth of the country (proxied by GDP per capita), similar to what was found in a review of indirect costs of various chronic diseases [111], possibly due to differences in the availability and affordability of diabetes care between HICs and LMICs [112, 113].”